Everything below concerns DAC linker. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-01-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Overall the missing information include[s] quantitative data on the composition and specifications of yohimbe bark and its preparations used in food and food supplements covering other alkaloids besides yohimbine, data on the bioavailability of active ingredients from the yohimbe bark extract and data on the toxicity of well specified individual preparations of yohimbe bark and the major yohimbe bark alkaloids, especially regarding subchronic toxicity, genotoxicity and reproductive toxicity. One study found that samples of brands sold in American brick-and-mortar stores contained highly variable amounts of yohimbine, with some brands of "yohimbe" not containing yohimbine from the P. johimbe tree, and other products containing no yohimbine at all. Labeling claims were often misleading. In analyses by other laboratories for products sold in the US, in other countries, and on the internet, highly variable content levels of yohimbine were revealed. Yohimbe sold in markets in West Africa where the tree grows may be adulterated with other species of the genus Pausinystalia, which contain little yohimbine. The amounts of alkaloid found even in genuine P. johimbe bark vary considerably, depending on the source of the bark (roots, stem, branches, height).
On April 12, 2023, it was announced that Cold Cave will tour in support of Depeche Mode's "Memento Mori" World Tour and will be at the following European dates and cities: May 16 & 18 in Amsterdam, Netherlands. May 20 in Antwerp, Belgium. May 23 in Stockholm, Sweden. May 26 in Leipzig, Germany. May 28 in Bratislava, Slovakia. In March 2025, the band was featured on vocals on a track called "So Then..." on a new album released by Chris Liebing.
== Epidemiology == The National Eye Institute reports keratoconus is the most common corneal dystrophy in the United States, affecting about one in 2,000 Americans, but some reports place the figure as high as one in 500. In the pediatric populations, ages three to 18, the prevalence of keratoconus was found to be as high as one in 334 children. The inconsistency may be due to variations in diagnostic criteria, with some cases of severe astigmatism interpreted as those of keratoconus, and vice versa. A long-term study found a mean incidence rate of 2.0 new cases per 100,000 population per year. Some studies have suggested a higher prevalence amongst females, or that people of South Asian ethnicity are 4.4 times as likely to develop keratoconus as Caucasians, and are also more likely to be affected with the condition earlier. Keratoconus is normally bilateral (affecting both eyes) although the distortion is usually asymmetric and is rarely completely identical in both corneas. Unilateral cases tend to be uncommon, and may in fact be very rare if a very mild condition in the better eye is simply below the limit of clinical detection. It is common for keratoconus to be diagnosed first in one eye and not until later in the other. As the condition then progresses in both eyes, the vision in the earlier-diagnosed eye will often remain poorer than that in its fellow.
The two institutes were originally located in the National Taiwan University's campus (Institutes of Biological Chemistry moved to Academia Sinica's campus later) to integrate research institutes and the University. Dr. Li had always been serving the chief consultant to assist the collaboration of the two institutes and international networking. The achievement of the two institutes today are built on Dr. Li's hard work. Dr. Li's foresight also brought about the domestic development of biotechnology and genetic engineering.
Opioid receptors are a group of inhibitory G protein-coupled receptors with opioids as ligands. The endogenous opioids are dynorphins, enkephalins, endorphins, endomorphins and nociceptin. Even though at the cellular level they are inhibitory, their activation is not always inhibitory: for example, activation of mu-opioid receptors activates (not inhibits) dopamine release, and activation of kappa-opioid receptors can lead to noradrenaline release, due to the location of these receptors on suppressor-cells releasing these neurotransmitters . The opioid receptors are ~40% identical to somatostatin receptors (SSTRs). Opioid receptors are distributed widely in the brain, in the spinal cord, on peripheral neurons, and digestive tract.
Sources: en.wikipedia.org
=== Notable donors === Woody Johnson, heir to the Johnson & Johnson fortune Jack Benaroya Barbara Davis Delta Tau Delta fraternity (official national philanthropy) Sheraton Grand Seattle – hosts annual 'Gingerbread Village' to raise funds for JDRF The Leona M. and Harry B. Helmsley Charitable Trust
*Rank presently absent in the Russian Army *The application of the ranks Polkovnik and General is only stable for small hosts. Large hosts are divided into divisions, and consequently the Russian Army sub-ranks General-mayor, General-leytenant and General-polkovnik are used to distinguish the atamans' hierarchy of command, the supreme ataman having the highest rank available. In this case, the shoulder insignia has a dedicated one-, two- and three-star alignment, as is normal in the Russian Army. Otherwise, it will be blank. As with the ranks Polkovnik and General, the Colonel ranks are only stable for small hosts, being given to atamans of regional and district status. The smallest unit, the stanitsa, is commanded by a Yesaul. If the region or district lacks any other stanitsas, the rank Polkovnik is applied automatically, but with no stars on the shoulder. As the hosts continue to grow, starless shoulder patches are becoming increasingly rare. In addition, the supreme ataman of the largest Don Cossack Host is officially titled Marshal, and so wears insignia derived from the Russian/Soviet Marshal ranks, including the diamond Marshal Star. This is because the Don Cossack Supreme Ataman is recognized as the official head of all Cossack armies, including those outside the present Russian borders. He also has the authority to recognize and dissolve new hosts.
The cephalopod radula consists of multiple symmetrical rows of up to nine teeth – thirteen in fossil classes. The organ is reduced or even vestigial in certain octopus species and is absent in Spirula. The teeth may be homodont (i.e. similar in form across a row), heterodont (otherwise), or ctenodont (comb-like). Their height, width and number of cusps is variable between species. The pattern of teeth repeats, but each row may not be identical to the last; in the octopus, for instance, the sequence repeats every five rows. Cephalopod radulae are known from fossil deposits dating back to the Ordovician. They are usually preserved within the cephalopod's body chamber, commonly in conjunction with the mandibles; but this need not always be the case; many radulae are preserved in a range of settings in the Mason Creek. Radulae are usually difficult to detect, even when they are preserved in fossils, as the rock must weather and crack in exactly the right fashion to expose them; for instance, radulae have only been found in nine of the 43 ammonite genera, and they are rarer still in non-ammonoid forms: only three pre-Mesozoic species possess one.
Vanguard S&P Small-Cap 600 ETF (NYSE Arca: VIOO) SPDR Portfolio S&P 600 Small Cap ETF (NYSE Arca: SPSM) iShares Core S&P Small-Cap ETF (NYSE Arca: IJR) These index funds may be reconstituted at different intervals resulting in a small difference in holdings.
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.